About Us
Red Abbey Team
Portfolio
News & Events
Contact Us

 

 

 

Red Abbey Venture Partners

Red Abbey Venture Partners is a life sciences investment firm that was founded in 2004. Since that time, we have invested in 14 privately held and 9 publicly traded life sciences companies. Our mission is to generate superior, risk-adjusted returns by investing in young companies that are developing the next generation of drugs and devices, as well as companies that are supporting these efforts with novel tools and products. Specifically, we are seeking to invest across the life sciences spectrum, which includes biotechnology, specialty pharmaceutical, medical device, diagnostics and research tools companies.

We believe that the life sciences sector has retained an “innovative edge” and that these companies will help people lead longer, healthier, more productive lives.

As such, we are:
      1) Targeting important diseases where the upside of success is significant;
      2) Investing in companies with a unique combination of high quality management and technology.

Our investment team and advisors are a multi-faceted group of individuals who possess a deep network of relationships. Furthermore, our experience in all aspects of these companies – scientific, financial, operational – provides us with the ability to conduct exceptional due diligence and add meaningful value to our portfolio companies.

   

 

RECENT NEWS

June 6, 2008

GlaxoSmithKline acquires Sirtris Pharmaceuticals, Inc., a world leader in sirtuin research and development.
Click here to learn more.

January 22, 2008

Teva to Acquire CoGenesys.
Acquisition Will Bolster Teva’s Biotechnology Capabilities.
Click here to learn more.

         
Copyright © 2004 - 2008  •  RED ABBEY VENTURE PARTNERS  •  All Rights Reserved
 Site Creation: Dezign Precision, Inc.